{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T17:27:50Z","timestamp":1794331670872,"version":"4.9.0"},"reference-count":14,"publisher":"Elsevier BV","issue":"42","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008771","name":"Animal and Plant Quarantine Agency","doi-asserted-by":"publisher","award":["B-1543418-2020-22-01"],"award-info":[{"award-number":["B-1543418-2020-22-01"]}],"id":[{"id":"10.13039\/501100008771","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.vaccine.2021.08.089","type":"journal-article","created":{"date-parts":[[2021,9,14]],"date-time":"2021-09-14T08:02:24Z","timestamp":1631606544000},"page":"6201-6205","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Development of a recombinant H9N2 influenza vaccine candidate against the Y280 lineage field virus and its protective efficacy"],"prefix":"10.1016","volume":"39","author":[{"given":"Do-Young","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Myung","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun-Kyu","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3411-3498","authenticated-orcid":false,"given":"Seo-jeong","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myoung-Heon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youn-Jeong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun-Mi","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2021.08.089_b0005","doi-asserted-by":"crossref","first-page":"9363","DOI":"10.1073\/pnas.96.16.9363","article-title":"Molecular characterization of H9N2 influenza viruses: were they the donors of the \u201cinternal\u201d genes of H5N1 viruses in Hong Kong?","volume":"96","author":"Guan","year":"1999","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.vaccine.2021.08.089_b0010","doi-asserted-by":"crossref","first-page":"620","DOI":"10.3390\/v11070620","article-title":"A global perspective on H9N2 avian influenza virus","volume":"11","author":"Peacock","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2021.08.089_b0015","first-page":"379","article-title":"An occurrence of non-highly pathogenic avian influenza in Korea","volume":"47","author":"Mo","year":"2003","journal-title":"Avian Dis"},{"key":"10.1016\/j.vaccine.2021.08.089_b0020","article-title":"Sequence analysis of the hemagglutinin gene of H9N2 Korean avian influenza viruses and assessment of the pathogenic potential of isolate MS96","volume":"527\u201335","author":"Lee","year":"2000","journal-title":"Avian Dis"},{"key":"10.1016\/j.vaccine.2021.08.089_b0025","doi-asserted-by":"crossref","first-page":"67","DOI":"10.4142\/jvs.2008.9.1.67","article-title":"An inactivated vaccine to control the current H9N2 low pathogenic avian influenza in Korea","volume":"9","author":"Choi","year":"2008","journal-title":"J Vet Sci"},{"key":"10.1016\/j.vaccine.2021.08.089_b0030","doi-asserted-by":"crossref","DOI":"10.4142\/jvs.2021.22.e21","article-title":"Genetic characterization of H9N2 avian influenza virus previously unrecognized in Korea","volume":"22","author":"Heo","year":"2021","journal-title":"J Vet Sci"},{"key":"10.1016\/j.vaccine.2021.08.089_b0035","first-page":"82","article-title":"The multifaceted zoonotic risk of H9N2 avian influenza","volume":"5","author":"Pusch","year":"2018","journal-title":"Veterinary Sci"},{"key":"10.1016\/j.vaccine.2021.08.089_b0040","doi-asserted-by":"crossref","first-page":"5181","DOI":"10.1128\/JVI.02827-06","article-title":"Amino acid 226 in the hemagglutinin of H9N2 influenza viruses determines cell tropism and replication in human airway epithelial cells","volume":"81","author":"Wan","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2021.08.089_b0045","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/zph.12685","article-title":"Human-infecting influenza A (H9N2) virus: a forgotten potential pandemic strain?","volume":"67","author":"Song","year":"2020","journal-title":"Zoonoses Publ Health"},{"key":"10.1016\/j.vaccine.2021.08.089_b0050","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1126\/science.1097211","article-title":"Mapping the antigenic and genetic evolution of influenza virus","volume":"305","author":"Smith","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2021.08.089_b0055","doi-asserted-by":"crossref","first-page":"6108","DOI":"10.1073\/pnas.100133697","article-title":"A DNA transfection system for generation of influenza A virus from eight plasmids","volume":"97","author":"Hoffmann","year":"2000","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.vaccine.2021.08.089_b0060","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1007\/s007050170002","article-title":"Universal primer set for the full-length amplification of all influenza A viruses","volume":"146","author":"Hoffmann","year":"2001","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2021.08.089_b0065","doi-asserted-by":"crossref","first-page":"6080","DOI":"10.1016\/j.vaccine.2020.07.033","article-title":"Immunogenicity and protective efficacy of clade 2.3. 2.1 c and clade 2.3. 4.4 c H5Nx avian influenza antigen bank vaccines in mice, Korea","volume":"38","author":"Kim","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.08.089_b0070","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.vetmic.2008.02.005","article-title":"Generation and evaluation of reassortant influenza vaccines made by reverse genetics for H9N2 avian influenza in Korea","volume":"130","author":"Song","year":"2008","journal-title":"Veterinary Microbiol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2101149X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2101149X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:01:43Z","timestamp":1759402903000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X2101149X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":14,"journal-issue":{"issue":"42","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S0264410X2101149X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.08.089","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a recombinant H9N2 influenza vaccine candidate against the Y280 lineage field virus and its protective efficacy","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.08.089","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}